A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia

PHASE2TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

January 16, 2023

Study Completion Date

March 27, 2023

Conditions
Achondroplasia
Interventions
BIOLOGICAL

Recifercept

Recifercept

Trial Locations (16)

2650

Universitair Ziekenhuis Antwerpen, Edegem

3000

Universitaire Ziekenhuizen Leuven (UZ Leuven), Leuven

3052

Murdoch Children's Research Institute, Melbourne

Murdoch Children's Research Institute, Parkville

19803

Nemours Alfred I duPont Hospital for Children, Wilmington

77030

Texas Children's Hospital, Houston

90502

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance

90806

MemorialCare Sleep Disorders Center at Long Beach Memorial Medical Center, Long Beach

92604

Ocean Sleep Medicine, Irvine

92656

Ocean Sleep Medicine, Aliso Viejo

DK-2400

DanTrials ApS, Copenhagen NV

00168

Fondazione Policlinico Universitario Agostino - Gemelli IRCCS, Roma

565-0871

Osaka University Hospital, Suita

700-8558

Okayama University Hospital, Okayama

3000-602

Centro Hospitalar e Universitário de Coimbra - Hospital Pediátrico, Coimbra

01008

Hospital Vithas San Jose, Vitoria-Gasteiz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY